Aldeyra Therapeutics, Inc. (ALDX)
4.63
+0.22
(+4.99%)
USD |
NASDAQ |
Jan 16, 16:00
4.61
-0.02
(-0.43%)
After-Hours: 20:00
Aldeyra Therapeutics Total Liabilities (Quarterly): 28.56M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 135.14M |
| ADMA Biologics, Inc. | 137.50M |
| Exelixis, Inc. | 662.85M |
| Altimmune, Inc. | 32.85M |
| Actinium Pharmaceuticals, Inc. | 42.37M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 77.80M |
| Shareholders Equity (Quarterly) | 49.24M |
| Debt to Equity Ratio | 0.3156 |
| Current Ratio | 2.680 |
| Net Debt Paydown Yield | 0.01% |